Results 181 to 190 of about 787,270 (314)

Basement membrane biosynthesis as a target for developing inhibitors of angiogenesis with anti-tumor properties

, 1993
Michael E. Maragoudakis, E Missirlis, George Karakiulakis, Mariana Sarmonica, Maria Bastakis, Nikos E. Tsopanoglou   +5 more
openalex   +1 more source

Bioengineering a Patient‐Derived Vascularized Lung Tumor‐on‐Chip Model to Decipher Immunomodulation by the Endothelium

Advanced Healthcare Materials, EarlyView.
Most in vitro cancer models lack cellular diversity, functional complexity, and clinical relevance. This work highlights the generation of an innovative dynamic tetraculture with autologous patient‐derived cells within a vascularized tumor‐on‐chip, as well as the recapitulation of endothelial anergy features induced by the tumor microenvironment ...
Christine Lansche, Ségolène Ladaigue, Giacomo Gropplero, Nicolas Zimmermann, Martin Nurmik, Irina Veith, Manh‐Louis Nguyen, Solenn Brosseau, Nicolas Poté, Pierre Mordant, Arnaud Roussel, Fathia Mami‐Chouaib, Fatima Mechta‐Grigoriou, Gérard Zalcman, Fabrice Soncin, Stéphanie Descroix, Maria Carla Parrini   +16 more
wiley   +1 more source

Angiogenic Factors and Inflammatory Bowel Diseases. [PDF]

Biomedicines
Li Z, Zeng L, Huang W, Zhang X, Zhang L, Xie Q.   +5 more
europepmc   +1 more source

Anticancer effects of chemoembolization using microspheres of an angiogenesis inhibitor (TNP-470) in rabbits bearing VX-2 carcinoma.

, 1992
Hiroaki Okada, Shigeru Kamei, Toshio Yoshioka, Yayoi Inoue, Yasuaki Ogawa, Hajime Toguchi   +5 more
openalex   +2 more sources

Enhanced angiogenesis induced by diffusible angiogenic growth factors released from human dental pulp explants of orthodontically moved teeth [PDF]

, 1998
Kathryn Derringer, R.W.A. Linden
openalex   +1 more source

An In Situ Curing, Shear‐Responsive Biomaterial Designed for Durable Embolization of Microvasculature

Advanced Healthcare Materials, EarlyView.
NeoCast is a next‐generation, solvent‐free, non‐adhesive liquid embolic designed for indications where deep occlusion is desired (e.g., tumors and chronic subdural hematoma). This novel agent offers ideal embolic properties: injectability, controllability, excellent visibility, and biocompatibility.
Quynh P. Pham, Jeffrey V. Groom II, Chander Sadasivan, David J. Fiorella, David C. Madoff, Lee‐Jae Guo, Michael Fornaciari, Courtney Guertin, Craig Wiltsey, Lee Core, Jonathan Merlo, William Wustenberg, Renu Virmani, Adam S. Arthur, Robert S. Langer, George M. Whitesides, Upma Sharma   +16 more
wiley   +1 more source

Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives. [PDF]

Signal Transduct Target Ther
Lee C, Kim MJ, Kumar A, Lee HW, Yang Y, Kim Y.   +5 more
europepmc   +1 more source

Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. [PDF]

, 1998
Bela Sharma, Melissa Handler, Inge Eichstetter, John M. Whitelock, Matthew A. Nugent, Renato V. Iozzo   +5 more
openalex   +1 more source

Glucocorticoids Alter Bone Microvascular Barrier via MAPK/Connexin43 Mechanisms

Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
Osteoporosis induced by Glucocorticoids (GCs) is a common complication of long‐term GC use in patients with inflammatory and autoimmune conditions, often leading to an increased fracture risk. A 3D bicellular endo‐osteo microfluidic platform is developed to explore pathogenic mechanisms underlying GCs‐induced osteoporosis, highlighting a novel MAPK ...
Eun‐Jin Lee, Peter Lialios, Micaila Curtis, James Williams IV, Yoontae Kim, Paul Salipante, Steven Hudson, Mandy B. Esch, Moshe Levi, Joanna Kitlinska, Stella Alimperti   +10 more
wiley   +1 more source

Mechanism of Curcumol Targeting the OTUB1/TGFBI Ubiquitination Pathway in the Inhibition of Angiogenesis in Colon Cancer. [PDF]

Int J Mol Sci
Zhu Y, Wu W, Hou D, Zhao Y, Ye J, Shen L, Zhao T, Wu X.   +7 more
europepmc   +1 more source